Desktop Genetics Introduces New Series of Customizable CRISPR Libraries – Technology Networks
Technology Networks |
Desktop Genetics Introduces New Series of Customizable CRISPR Libraries
Technology Networks The series consists of six new CRISPR library products, each of which can be tailored to an investigator’s list of genomic targets using any delivery method. Each product addresses a particular experimental application of the genome editing technology: Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease ResearchBusiness Wire (press release) |
Technology Networks |
Desktop Genetics Introduces New Series of Customizable CRISPR Libraries
Technology Networks The series consists of six new CRISPR library products, each of which can be tailored to an investigator’s list of genomic targets using any delivery method. Each product addresses a particular experimental application of the genome editing technology: Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease ResearchBusiness Wire (press release) |
Kaiser Health News |
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
Kaiser Health News Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country’s first gene therapy, Novartis’ Kymriah, a leukemia treatment approved in August. But the total costs of Kymriah and the … Patients could end up paying more than $1M for new gene therapyBecker’s Hospital Review |
|
IMP321 New Data Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting
Nasdaq SYDNEY, Australia, Oct. 17, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that new data investigating the use of eftilagimod alpha (IMP321), the Company’s lead product candidate, in combination with … |